| Literature DB >> 26279621 |
Mrudul R Keskar1, Ravin M Jugade1.
Abstract
Cefixime trihydrate is a broad spectrum cephalosporin antibiotic, effective against gram-positive and gram-negative bacterial infections. Simple and rapid method has been developed for the determination of cefixime trihydrate in bulk and pharmaceutical formulations. This method was based on the formation of bluish-green ion-pair complex of cefixime trihydrate with bromophenol blue in dimethyl sulfoxide (DMSO)-acetonitrile medium. Different parameters were studied and optimized. A 2:1 complex was formed between the drug and reagent almost instantaneously at room temperature which has λmax of 610 nm. Under optimum conditions, calibration curve was found to be linear over the range of 10-130 μg mL(-1). The method was subjected to analytical quality control. The limit of detection was found to be 1.08 μg mL(-1). Recovery studies and interference studies were carried out. The proposed method was successfully applied to the determination of cefixime trihydrate in bulk and pharmaceutical formulations with high precision and accuracy.Entities:
Keywords: Cefixime trihydrate; bromophenol blue; ion-pair complex
Year: 2015 PMID: 26279621 PMCID: PMC4517833 DOI: 10.4137/ACI.S28463
Source DB: PubMed Journal: Anal Chem Insights ISSN: 1177-3901
Figure 1Structure of cefixime trihydrate (A) and bromophenol blue (B).
Figure 2Absorption spectra of (a) cefixime trihydrate (508 μg mL−1), (b) bromophenol blue (8 μM), and (c) their complex.
Figure 3Continuous variation plots for the ion-pair complex of cefixime trihydrate (a) 1 × 10−4 and (b) 5 × 10−5 with bromophenol blue.
Figure 4Proposed structure of ion-pair complex of cefixime trihydrate and bromophenol blue.
Figure 5Effect of time on the absorbance of ion-pair complex of cefixime trihydrate with bromophenol blue.
Figure 6Effect of bromophenol blue concentration on ion-pair complex of cefixime trihydrate (a) 100 μg mL−1 and (b) 200 μg mL−1.
Qualitative and statistical parameters for proposed method.
| PARAMETER | FINDINGS |
|---|---|
| Solvent | Dimethyl sulfoxide-Acetonitrile |
| λmax (nm) | 610 |
| Molar ratio (D:R) | 2:1 |
| Linear range (μg mL−1) | 10–130 |
| Linear regression equation | Y = 0.0014X (μg mL−1) − 0.0153 |
| Sandell’s sensitivity (μg cm−2) | 0.6678 |
| Correlation coefficient (r) | 0.9981 |
| Coefficient of determination (r2) | 0.9962 |
| Stability constant (log K) | 6.25 ± 0.90 |
| Molar absorptivity (L mol−1 cm−1) | 7.59 × 102 |
| LOD | 1.08 |
| LOQ | 3.61 |
| % RSD | 3.09 |
| ΔGod (J mol−1) | −3.6259 × 104 |
Notes:
Limit of detection,
Limit of quantification,
Relative standard deviation,
Gibb’s free energy change.
Recovery studies of cefixime trihydrate.
| DRUG | TAKEN (μg mL−1) | FOUND (μg mL−1) | RECOVERY (%) | MEAN ± SD |
|---|---|---|---|---|
| Cefixime trihydrate | 25.0 | 24.5 | 98.0 | |
| 75.0 | 77.0 | 102.7 | 100.3 ± 2.4 | |
| 115.0 | 115.5 | 100.3 |
Note:
(Avg ± SD) of three determinations.
Evaluation of inter-day and intra-day precision and accuracy.
| DRUG | TAKEN (μg mL−1) | INTER-DAY (n = 3) | INTRA-DAY (n = 3) | ||||
|---|---|---|---|---|---|---|---|
| FOUND | % RSD | % RE | FOUND | % RSD | % RE | ||
| Cefixime trihydrate | 25.0 | 25.5 | 3.9 | 2.0 | 24.5 | 2.9 | 2.0 |
| 75.0 | 77.5 | 3.1 | 3.3 | 77.0 | 1.5 | 2.7 | |
| 115.0 | 117.0 | 0.9 | 0.9 | 115.5 | 0.6 | 0.4 | |
Note:
Average of three determinations.
Abbreviations: RSD, Relative Standard Deviation; RE, Relative Error.
Evaluation of robustness.
| DRUG | TAKEN (μg mL−1) | ROBUSTNESS REACTION TIME |
|---|---|---|
| Cefixime trihydrate | 25.0 | 2.6 |
| 75.0 | 0.6 | |
| 115.0 | 0.9 |
Note:
Reaction time (15 ± 5 min).
Determination of cefixime trihydrate in presence of excipients.
| EXCIPIENTS | AMOUNT ADDED (mg) | CEFIXIME TRIHYDRATE |
|---|---|---|
| Lactose | 20.0 | 99.4 ± 0.8 |
| Dextrose | 20.0 | 96.2 ± 0.5 |
| Cellulose | 20.0 | 98.6 ± 0.4 |
| Magnesium stearate | 20.0 | 101.1 ± 0.7 |
| Talc | 20.0 | 98.2 ± 0.2 |
| Starch | 20.0 | 97.4 ± 0.8 |
| Gelatine | 20.0 | 98.9 ± 0.7 |
Note:
75 (μg mL−1) of cefixime trihydrate.
Analysis of pharmaceutical formulations.
| PHARMACEUTICAL PREPARATION | LABELED AMOUNT (mg) | FOUND AMOUNT (mg) | |
|---|---|---|---|
| CALIBRATION CURVE METHOD | STANDARD ADDITION METHOD | ||
| Zif | 50.0 | 55.6 ± 0.5 | 50.4 ± 0.7 |
| Zif | 200.0 | 202.6 ± 0.6 | 195.6 ± 1.1 |
| Cefalac | 50.0 | 50.3 ± 1.9 | 49.8 ± 1.4 |
Notes:
Average of three determinations.
FDC Limited.
Macleods pharmaceutical limited.
Comparison of present work with reported methods.
| DRUG | REAGENT USED | LINEAR RANGE (μg mL−1) | LOD (μg mL−1) | MOLAR ABSORPTIVITY (L mol−1 cm−1) | APPLICATIONS | REFERENCE |
|---|---|---|---|---|---|---|
| Cefixime trihydrate | 7,7,8,8-tetracyanoquinodi methane (TCNQ) | 10–240 | 1.10 | 2.3 × 103 | Capsules | |
| Iodine | 0.35–17.5 | 3.80 | 1.32 × 104 | Capsules | ||
| Methyl orange | 0.5–50 | – | 1.02405 × 105 | Tablets | ||
| Methylene blue | 2.0–505 | – | 6.6928 × 104 | Tablets | ||
| 8-hydroxy-1,3,6-pyrenetri sulfonic acid trisodium salt (HPTS) | 0.1–0.6 | 0.03 | 1.5 × 106 | Capsules | ||
| 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-CI) | 20–100 | 1.51 | – | Capsules | ||
| Congo red | 20–65 | – | – | – | ||
| Bromophenol blue | 10–130 | 1.08 | 7.59 × 102 | Tablets, oral suspension | Present work |